SCHEMBL20203823

SCHEMBL20203823

CC(C)C(=O)NNc1cnc(Cl)cn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
SMN1; SMN2 Q16637 6/20 0.44
GAA P10253 4/20 0.44
KDM4E B2RXH2 1/20 0.40
HTT P42858 1/20 0.40
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
TP53 P04637 2/20 0.37
SIRT6 Q8N6T7 1/20 0.37
S1PR2 O95136 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 1/20 0.35
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
CDK5 Q00535 1/20 0.34
DEGS1 O15121 1/20 0.33
PTK2 Q05397 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23454225 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2GAAKDM4ESIRT6
SCHEMBL23454259 0.81 GAA (0.41) ALDH1A1SMN1; SMN2GAANPC1RAB9A
SCHEMBL23454261 0.81 GAA (0.41) ALDH1A1SMN1; SMN2GAANPC1RAB9A
SCHEMBL23454368 0.81 GAA (0.41) ALDH1A1SMN1; SMN2GAANPC1RAB9A
SCHEMBL10877982 0.73 POLB (0.56) ALDH1A1SMN1; SMN2GAAKDM4EHTT
SCHEMBL20189743 0.72 GAA (0.43) ALDH1A1SMN1; SMN2GAAHTTNPC1
SCHEMBL21835691 0.72 JUN (0.38) ALDH1A1SMN1; SMN2GAASIRT6S1PR2
SCHEMBL30448357 0.72 GAA (0.43) ALDH1A1SMN1; SMN2GAAHTTNPC1
SCHEMBL4074315 0.72 FDPS (0.46) SMN1; SMN2GAAKDM4ENPC1RAB9A
SCHEMBL1284641 0.72 FFAR2 (0.49) ALDH1A1SMN1; SMN2GAAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322790-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. 2023-10-12 US disclosed
US-20210188852-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. 2021-06-24 US disclosed
WO-2018098499-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. (US) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188852-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B ALDH1A1 916/4885SMN1; SMN2 334/4885GAA 832/4885
US-20230322790-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B ALDH1A1 916/4885SMN1; SMN2 334/4885GAA 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.